Application of GPCR Structures for Modelling of Free Fatty Acid Receptors
- PMID: 27757764
- DOI: 10.1007/164_2016_52
Application of GPCR Structures for Modelling of Free Fatty Acid Receptors
Abstract
Five G protein-coupled receptors (GPCRs) have been identified to be activated by free fatty acids (FFA). Among them, FFA1 (GPR40) and FFA4 (GPR120) bind long-chain fatty acids, FFA2 (GPR43) and FFA3 (GPR41) bind short-chain fatty acids and GPR84 binds medium-chain fatty acids. Free fatty acid receptors have now emerged as potential targets for the treatment of diabetes, obesity and immune diseases. The recent progress in crystallography of GPCRs has now enabled the elucidation of the structure of FFA1 and provided reliable templates for homology modelling of other FFA receptors. Analysis of the crystal structure and improved homology models, along with mutagenesis data and structure activity, highlighted an unusual arginine charge-pairing interaction in FFA1-3 for receptor modulation, distinct structural features for ligand binding to FFA1 and FFA4 and an arginine of the second extracellular loop as a possible anchoring point for FFA at GPR84. Structural data will be helpful for searching novel small-molecule modulators at the FFA receptors.
Keywords: Allosteric site; FFA1; FFA2; FFA3; FFA4; Free fatty acid receptors; G protein-coupled receptors; GPR84; Molecular modelling; Mutagenesis; Orthosteric site; SAR.
Similar articles
-
Free fatty acid receptors: structural models and elucidation of ligand binding interactions.BMC Struct Biol. 2015 Sep 7;15:16. doi: 10.1186/s12900-015-0044-2. BMC Struct Biol. 2015. PMID: 26346819 Free PMC article.
-
Role of free fatty acid receptors in the regulation of energy metabolism.Biochim Biophys Acta. 2014 Sep;1841(9):1292-300. doi: 10.1016/j.bbalip.2014.06.002. Epub 2014 Jun 10. Biochim Biophys Acta. 2014. PMID: 24923869 Review.
-
Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids.J Biol Chem. 2008 Nov 21;283(47):32913-24. doi: 10.1074/jbc.M805601200. Epub 2008 Sep 18. J Biol Chem. 2008. PMID: 18801738
-
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.Br J Pharmacol. 2009 Sep;158(1):146-53. doi: 10.1111/j.1476-5381.2009.00421.x. Br J Pharmacol. 2009. PMID: 19719777 Free PMC article. Review.
-
Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.Front Endocrinol (Lausanne). 2012 Oct 2;3:111. doi: 10.3389/fendo.2012.00111. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 23060857 Free PMC article.
Cited by
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer's Disease Mouse Model.Int J Mol Sci. 2022 Mar 24;23(7):3533. doi: 10.3390/ijms23073533. Int J Mol Sci. 2022. PMID: 35408893 Free PMC article.
-
Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease.Neurotox Res. 2020 Oct;38(3):596-602. doi: 10.1007/s12640-020-00238-5. Epub 2020 Jun 22. Neurotox Res. 2020. PMID: 32572814 Free PMC article.
-
Short-Chain Fatty Acid Receptors and Cardiovascular Function.Int J Mol Sci. 2022 Mar 18;23(6):3303. doi: 10.3390/ijms23063303. Int J Mol Sci. 2022. PMID: 35328722 Free PMC article. Review.
-
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.Int J Mol Sci. 2021 Feb 10;22(4):1763. doi: 10.3390/ijms22041763. Int J Mol Sci. 2021. PMID: 33578942 Free PMC article. Review.
-
Novel Pharmacotherapies in Parkinson's Disease.Neurotox Res. 2021 Aug;39(4):1381-1390. doi: 10.1007/s12640-021-00375-5. Epub 2021 May 18. Neurotox Res. 2021. PMID: 34003454 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous